NCT00828204 Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects Status COMPLETED Phase PHASE3
NCT00819195 Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis Status COMPLETED Phase N/A
NCT00813709 Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX) Status COMPLETED Phase PHASE3
NCT00812474 Regional Cortical Cerebral Quantitative MRI Perfusion Correlation Neurocognition in Multiple Sclerosis Status COMPLETED Phase N/A
NCT00811902 Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00811395 Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00803049 Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00799942 Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus Status TERMINATED Phase PHASE2
NCT00799890 Sunphenon in Progressive Forms of Multiple Sclerosis Status COMPLETED Phase PHASE2/PHASE3
NCT00794352 Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System Status RECRUITING Phase N/A
NCT00784836 Immunogenicity and Safety of Subcutaneously-administered Avonex (Interferon Beta-1a) in Multiple Sclerosis (MS) Patients Status TERMINATED Phase PHASE3
NCT00776048 Validation of an Obstacle Course Used in Patients With Muscle Tightness Status UNKNOWN Phase N/A
NCT00772525 Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE2